Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Meinhold-Heerlein I, Fotopoulou C, Harter P, Kurzeder C, Mustea A, Wimberger P et al (2016) The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Arch Gynecol Obstet 293:695–700
2. Missaoui N, Salhi S, Bdioui A, Mestiri S, Abdessayed N, Mokni M et al (2018) Immunohistochemical characterization improves the reproducibility of the histological diagnosis of ovarian carcinoma. Asian Pac J Cancer Prev 19:2545–2551
3. McCluggage WG, Lyness RW, Atkinson RJ, Dobbs SP, Harley I, McClelland HR et al (2002) Morphological effects of chemotherapy on ovarian carcinoma. J Clin Pathol 55:27–31
4. Ivantsov AO (2018) Pathological response of ovarian cancer to neoadjuvant chemotherapy. Chin Clin Oncol 7:59
5. Williams AT, Ganesan R (2020) Role of the pathologist in assessing response to treatment of ovarian and endometrial cancers. Histopathology 76:93–101